In our mouse study, the human lung cancer cells were injected subcutaneously into the mouse’s abdominal flank and the drug, CB1a peptide, was infused subcutaneously into the dorsolateral neck of the mouse (Figure 5A). This evidence concerns the gene CNR1 and lung cancer.